These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8492635)

  • 1. [Treatment of prostatic cancer (Drug Administration, Sweden)].
    Lakartidningen; 1993 May; 90(18):1766, 1769-73. PubMed ID: 8492635
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cycloplatam in the treatment of patients with disseminated prostatic cancer].
    Matveev BP; Gorbunova VA; Smirnova NB; Zhumagazin ZhD; Bukharkin BV; Orel NF
    Urol Nefrol (Mosk); 1996; (3):34-6. PubMed ID: 8928330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostatic cancer].
    Soulié M; Barré C; Beuzeboc P; Chautard D; Cornud F; Eschwege P; Fontaine E; Molinié V; Moreau JL; Péneau M; Ravery V; Rébillard X; Richaud P; Ruffion A; Salomon L; Staerman F; Villers A;
    Prog Urol; 2004 Nov; 14(4 Suppl 1):913, 915-55. PubMed ID: 15779654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Topics of prostate cancer].
    Tomida K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):43-6. PubMed ID: 19195118
    [No Abstract]   [Full Text] [Related]  

  • 5. Current strategies in the treatment of metastatic hormone-refractory prostate cancer.
    Ghosn M; Kattan J; Younes F
    Tunis Med; 2005 Dec; 83 Suppl 12():74. PubMed ID: 16430073
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer chemotherapy: emerging from the shadows.
    Roth BJ
    J Clin Oncol; 2005 May; 23(15):3302-3. PubMed ID: 15738529
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant systemic therapy of prostate cancer.
    Raghavan D
    Semin Oncol; 1995 Dec; 22(6):633-40. PubMed ID: 8539638
    [No Abstract]   [Full Text] [Related]  

  • 8. Cooperative clinical of single and combined agent protocols: adjuvant protocols. National Prostatic Cancer Project Cooperative Clinical Trials.
    Gibbons RP
    Urology; 1981 Apr; 17(4 Suppl):48-52. PubMed ID: 7010762
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of the individual stages of prostatic cancer at the time of diagnosis].
    Mogensen P; Frimodt-Møller C
    Ugeskr Laeger; 1981 Jun; 143(26):1644-6. PubMed ID: 7292724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyproterone acetate (Androcur-depo) in the treatment of inoperable prostatic cancer].
    Stepanov VN; Goriunov VG; Chechenin MG; Sivkov AV; Gubdurakhmanov II
    Urol Nefrol (Mosk); 1995; (6):33-6. PubMed ID: 8686122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer].
    Rusakov IG; Alekseev BIa
    Urologiia; 2002; (5):23-6. PubMed ID: 12402771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of locally spread prostate cancer].
    Tammela T
    Duodecim; 2005; 121(16):1779-82. PubMed ID: 16268225
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide).
    Isurugi K; Niijima T; Akaza H; Aso Y; Koiso K; Fuse M; Okada K; Usami M; Ohashi T; Ueda T;
    J Chemother; 1989 Jul; 1(4 Suppl):1237-41. PubMed ID: 16312848
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program].
    Fourcade RO; Richaud P; Coloby P; Malavaud B;
    Prog Urol; 2007 Jun; 17(4 Suppl 1):891-910. PubMed ID: 17650746
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early versus late hormonal treatment in advanced prostate cancer].
    Allepuz Losa C; Gil Martínez P; Gil Sanz MJ; Rioja Sanz LA
    Actas Urol Esp; 1999; 23(7):557-64. PubMed ID: 10488608
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of mitoxantrone in the treatment of hormone-independent metastatic cancer of the prostate].
    Culine S
    Prog Urol; 2002 Feb; 12(1 Suppl 2):31-5. PubMed ID: 11980025
    [No Abstract]   [Full Text] [Related]  

  • 17. PC-SPES withdrawal response.
    Chaudhary UB; Rashid M; Keane TE
    Acta Oncol; 2004; 43(8):772-3. PubMed ID: 15764226
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of efficacy of cyproterone acetate monotherapy in prostatic cancer].
    Gurina LI; Iudin SV; Rusakov IG; Bystrov AA
    Urologiia; 2003; (4):25-30. PubMed ID: 12942722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiopharmaceutical and chemotherapy combinations in metastatic castrate-resistant prostate cancer: a new beginning?
    Sartor O
    J Clin Oncol; 2009 May; 27(15):2417-8. PubMed ID: 19364953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.